Literature DB >> 22108499

Depolarized MUC1 expression is closely associated with hypoxic markers and poor outcome in resected non-small cell lung cancer.

Kyoichi Kaira1, Kazuo Nakagawa, Yasuhisa Ohde, Takehiro Okumura, Toshiaki Takahashi, Haruyasu Murakami, Masahiro Endo, Haruhiko Kondo, Takashi Nakajima, Nobuyuki Yamamoto.   

Abstract

MUC1 is transmembrane mucin aberrantly overexpressed in various cancers. However, little is known about how MUC1 expression is associated with hypoxia, glucose metabolism, and epidermal growth factor receptor (EGFR) pathway, which are related to cancer progression. The aim of this study is to evaluate the relationship between MUC1 expression and these molecular markers in lung cancer. Of all 126 patients, high-grade polarized expression (HP), low-grade polarized expression (LP), and depolarized expression (DP) group were 50 (39.7%), 35 (27.8%), and 41 (32.5%), respectively. Depolarized MUC1 expression was significantly associated with poor outcome and was closely correlated with glucose metabolism (Glut1), hypoxia (HIF-1α), angiogenesis (vascular endothelial growth factor and microvessel density), amino acid metabolism (LAT1), and EGFR expression. High-grade polarized MUC1 expression was associated with favorable prognosis and adenocarcinoma. Depolarized MUC1 expression was significantly associated with poor outcome. Glucose metabolism, hypoxia, angiogenesis, amino acid metabolism, and EGFR pathway may play an important role in the development of depolarized MUC1 expression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22108499     DOI: 10.1177/1066896911429296

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  9 in total

1.  Mucin-1 correlates with survival, smoking status, and growth patterns in lung adenocarcinoma.

Authors:  Elisa Lappi-Blanco; Johanna M Mäkinen; Siri Lehtonen; Henna Karvonen; Raija Sormunen; Kirsi Laitakari; Shirley Johnson; Riitta Mäkitaro; Risto Bloigu; Riitta Kaarteenaho
Journal:  Tumour Biol       Date:  2016-08-01

Review 2.  MUC1: a novel metabolic master regulator.

Authors:  Kamiya Mehla; Pankaj K Singh
Journal:  Biochim Biophys Acta       Date:  2014-01-11

3.  ATRA and Genistein synergistically inhibit the metastatic potential of human lung adenocarcinoma cells.

Authors:  Ji Cheng; Jun Qi; Xue-Tao Li; Kun Zhou; Jing-Han Xu; Yong Zhou; Guo-Qiang Zhang; Jian-Ping Xu; Ren-Jie Zhou
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 4.  MUC1 and metastatic cancer: expression, function and therapeutic targeting.

Authors:  Teresa M Horm; Joyce A Schroeder
Journal:  Cell Adh Migr       Date:  2013-01-09       Impact factor: 3.405

5.  Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC.

Authors:  Chunlei Ge; Ruilei Li; Haifeng Song; Tao Geng; Jinyan Yang; Qinghua Tan; Linfeng Song; Ying Wang; Yuanbo Xue; Zhen Li; Suwei Dong; Zhiwei Zhang; Na Zhang; Jiyin Guo; Lin Hua; Siyi Chen; Xin Song
Journal:  BMC Cancer       Date:  2017-12-21       Impact factor: 4.430

6.  MUC1 overexpression predicts worse survival in patients with non-small cell lung cancer: evidence from an updated meta-analysis.

Authors:  Xing Huang; Qi Sun; Chen Chen; Yi Zhang; Xin Kang; Jing-Yuan Zhang; Da-Wei Ma; Lei Xia; Lin Xu; Xin-Yu Xu; Bin-Hui Ren
Journal:  Oncotarget       Date:  2017-08-03

7.  Characterization of the expression of LAT1 as a prognostic indicator and a therapeutic target in renal cell carcinoma.

Authors:  Kosuke Higuchi; Shinichi Sakamoto; Keisuke Ando; Maihulan Maimaiti; Nobushige Takeshita; Kentaro Okunushi; Yoshie Reien; Yusuke Imamura; Tomokazu Sazuka; Kazuyoshi Nakamura; Jun Matsushima; Tomomi Furihata; Yuzuru Ikehara; Tomohiko Ichikawa; Naohiko Anzai
Journal:  Sci Rep       Date:  2019-11-20       Impact factor: 4.379

8.  Inhibition of hypoxia-induced Mucin 1 alters the proteomic composition of human osteoblast-produced extracellular matrix, leading to reduced osteogenic and angiogenic potential.

Authors:  Pavitra K Jadaun; Shuang Zhang; Marijke Koedam; Jeroen Demmers; Suvro Chatterjee; Johannes P van Leeuwen; Bram C van der Eerden
Journal:  J Cell Physiol       Date:  2021-10-22       Impact factor: 6.513

9.  MUC1 positive, Kras and Pten driven mouse gynecologic tumors replicate human tumors and vary in survival and nuclear grade based on anatomical location.

Authors:  Tejas S Tirodkar; Raluca A Budiu; Esther Elishaev; Lixin Zhang; Jyothi T Mony; Joan Brozick; Robert P Edwards; Anda M Vlad
Journal:  PLoS One       Date:  2014-07-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.